dacarbazine has been researched along with Cognition Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allgeier, A; Bottomley, A; de Gans, J; Delgadillo, D; Enting, RH; Gijtenbeek, AM; Habets, EJ; Hoang-Xuan, K; Klein, M; Nederend, S; Reijneveld, JC; Seute, T; Taphoorn, MJ; Tijssen, CC; van den Bent, MJ | 1 |
| Mukasa, A; Narita, Y; Saito, K; Saito, N; Shibui, S; Shinoura, N; Tabei, Y | 1 |
| Bosma, I; Buter, J; de Groot, M; Douw, L; Froklage, FE; Heimans, JJ; Klein, M; Lagerwaard, FJ; Oosterbaan, LJ; Postma, TJ; Reijneveld, JC; Sanchez, E; Sizoo, EM; Uitdehaag, BM | 1 |
| Benderitter, M; Bernier, MO; Brochet, B; Delattre, JY; Douzane, H; Durand, T; Feuvret, L; Hoang-Xuan, K; Jacob, S; Lebouil, L; Leclercq, D; Lestaevel, P; Milliat, F; Noël, G; Psimaras, D; Rahimian, A; Ricard, D; Tamarat, R; Vayatis, N | 1 |
| Brock, J; Chalmers, AJ; Lorimer, CF; Saran, F | 1 |
| Ajit, NE; Burton, GV; El-Osta, H; Peddi, P | 1 |
| Anderson, SK; Brown, PD; Cerhan, JH; Lageman, SK; Locke, DE; Wu, W | 1 |
| Iwata, H; Shibamoto, Y; Sugie, C | 1 |
| Bosma, I; Buter, J; Heimans, JJ; Hilverda, K; Klein, M; Peter Vandertop, W; Postma, TJ; Reijneveld, JC; Slotman, BJ | 1 |
| Brown, P; Buckner, J | 1 |
| Kiebert, G; Macdonald, DR; Olson, J; Prados, M; Yung, A | 1 |
| Bockenstedt, P; Krishnan, K | 1 |
2 review(s) available for dacarbazine and Cognition Disorders
| Article | Year |
|---|---|
Radiotherapy for metastatic brain tumors.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Cranial Irradiation; Dacarbazine; Dose Fractionation, Radiation; Humans; Patient Selection; Radiation Injuries; Radiosurgery; Radiotherapy, Adjuvant; Temozolomide; Treatment Outcome | 2009 |
Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Clinical Trials as Topic; Cognition Disorders; Dacarbazine; Disease Progression; Endpoint Determination; Glioblastoma; Health Status; Humans; Neuropsychological Tests; Procarbazine; Quality of Life; Survival Analysis; Temozolomide | 2005 |
10 other study(ies) available for dacarbazine and Cognition Disorders
| Article | Year |
|---|---|
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors.
Topics: Aged; Astrocytoma; Brain Neoplasms; Cognition Disorders; Cohort Studies; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Health Status; Humans; Male; Middle Aged; Neuropsychological Tests; Quality of Life; Radiotherapy; Statistics, Nonparametric; Survivors; Temozolomide; Tumor Suppressor Proteins | 2014 |
Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cognition Disorders; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Promoter Regions, Genetic; Retrospective Studies; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2014 |
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Atrophy; Brain Neoplasms; Cerebral Cortex; Cognition Disorders; Dacarbazine; Female; Glioma; Humans; Kaplan-Meier Estimate; Leukoencephalopathies; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Temozolomide; Young Adult | 2014 |
EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Dacarbazine; Early Diagnosis; Female; Follow-Up Studies; Glioma; Humans; Leukoencephalopathies; Male; Prospective Studies; Radiotherapy; Temozolomide | 2015 |
Glioblastoma in the elderly - How do we choose who to treat?
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Attitude of Health Personnel; Brain Neoplasms; Cognition Disorders; Cross-Sectional Studies; Dacarbazine; Frail Elderly; Geriatric Assessment; Glioblastoma; Humans; Neurologists; Oncologists; Patient Care Team; Patient Selection; Practice Patterns, Physicians'; Referral and Consultation; Temozolomide | 2016 |
Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cognition Disorders; Dacarbazine; Dexamethasone; Glioblastoma; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary; Piracetam; Temozolomide | 2016 |
Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Attention; Brain Neoplasms; Cognition Disorders; Dacarbazine; Female; Humans; Language; Male; Memory; Middle Aged; Neuropsychological Tests; Retrospective Studies; Space Perception; Temozolomide | 2010 |
Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Attention; Brain Neoplasms; Cognition Disorders; Dacarbazine; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Memory; Mental Processes; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Radiotherapy, Adjuvant; Temozolomide; Verbal Learning | 2010 |
Temozolomide: too early for definitive conclusions.
Topics: Adult; Age Factors; Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Clinical Trials as Topic; Cognition Disorders; Dacarbazine; Disease Progression; Glioma; Humans; Radiation Injuries; Reproducibility of Results; Temozolomide | 2003 |
Paraneoplastic cerebellar degeneration: a rare presentation of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cerebellar Diseases; Cognition Disorders; Dacarbazine; Diagnosis, Differential; Doxorubicin; Dysarthria; Female; Hodgkin Disease; Humans; Labyrinthitis; Meningitis; Nerve Degeneration; Nystagmus, Pathologic; Paraneoplastic Syndromes; Quality of Life; Remission Induction; Vinblastine; Vincristine | 1994 |